November 2025

The Associate Editor of Evidence-Based Oncology discusses the importance of advocacy.

The author, from Reimagine Care, discusses how AI can enhance oncology care by prioritizing patient needs, fostering trust, and streamlining communication through familiar text-based support for all ages.

AI is poised to transform oncology with innovative tools enhancing diagnosis, treatment, and clinical trials, despite some wariness from clinicians and patients.

A Stakeholder Interchange convened in Los Angeles, California, by The American Journal of Managed Care explores the treatment landscape for relapsed/refractory multiple myeloma, focusing on the challenges of bringing bispecific antibodies to patients in an outpatient setting.

A white paper explores how biomarker testing enhances patient outcomes and what barriers prevent access in several common cancers.

Experts discuss the urgent need for equitable access to cancer care, addressing barriers in treatment delivery and the importance of personalized medicine.

Experts discuss the intersection of innovation, affordability, and access in cancer care, focusing on multiple myeloma and NSCLC advancements.

Experts discuss the evolving landscape of CLL treatment, cellular therapies, and innovative diagnostics shaping patient care and cost-effectiveness in oncology.

Experts discuss the evolution of cancer care, emphasizing value-based approaches, precision oncology, and the importance of multidisciplinary collaboration for improved patient outcomes.

The number of Black, Hispanic, and Latino students admitted into medical schools fell as rates increased for White and Asian students.